Thursday, November 12, 2026
23 C
Bengaluru

The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research

The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research

In India, the medical landscape presents a glaring paradox: private hospitals treat roughly 60% of the nation’s patients, yet the vast majority of institutions without attached colleges produce fewer than 10 research papers a year on average. Meanwhile, public medical colleges and premier academic centres carry almost the entire burden of the nation's medical research output. A recent study published in the Journal of Medical Evidence (BMJ Group) has exposed this systemic failure. Conducted by Dr Samiran Nundy and Dr Paramanand Tiwari from Delhi’s Sir Ganga Ram Hospital, the study analysed research output from January 2021 to December 2025 across Scopus, PubMed, and Google Scholar. Their findings reveal a troubling reality: while India ranks 4th globally in the sheer volume of medical publications, it drops to 9th in citation impact. The country treats millions, but it is failing to learn from them. Here is a deep dive into what India is missing, why it matters, and how to fix it.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Topics

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img